vs
Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and Kymera Therapeutics, Inc. (KYMR). Click either name above to swap in a different company.
Kymera Therapeutics, Inc. is the larger business by last-quarter revenue ($11.5M vs $7.2M, roughly 1.6× GREENPOWER MOTOR Co INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -667.6%, a 602.0% gap on every dollar of revenue. On growth, GREENPOWER MOTOR Co INC. posted the faster year-over-year revenue change (-11.5% vs -55.3%).
GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.
Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.
GP vs KYMR — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.2M | $11.5M |
| Net Profit | $-4.7M | $-76.6M |
| Gross Margin | 14.6% | — |
| Operating Margin | — | -736.8% |
| Net Margin | -65.6% | -667.6% |
| Revenue YoY | -11.5% | -55.3% |
| Net Profit YoY | -2.1% | -82.1% |
| EPS (diluted) | $-0.17 | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $11.5M | ||
| Q1 25 | — | $22.1M | ||
| Q4 24 | $7.2M | $7.4M | ||
| Q3 24 | $5.3M | — | ||
| Q2 24 | $3.0M | $25.6M | ||
| Q1 24 | — | $10.3M | ||
| Q4 23 | $8.2M | $47.9M | ||
| Q3 23 | $8.4M | — |
| Q2 25 | — | $-76.6M | ||
| Q1 25 | — | $-65.6M | ||
| Q4 24 | $-4.7M | $-70.8M | ||
| Q3 24 | $-4.7M | — | ||
| Q2 24 | $-5.4M | $-42.1M | ||
| Q1 24 | — | $-48.6M | ||
| Q4 23 | $-4.6M | $-14.4M | ||
| Q3 23 | $-4.3M | — |
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 16.6% | — | ||
| Q3 23 | 14.6% | — |
| Q2 25 | — | -736.8% | ||
| Q1 25 | — | -336.8% | ||
| Q4 24 | — | -1092.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -198.5% | ||
| Q1 24 | — | -562.2% | ||
| Q4 23 | — | -40.3% | ||
| Q3 23 | — | — |
| Q2 25 | — | -667.6% | ||
| Q1 25 | — | -296.7% | ||
| Q4 24 | -65.6% | -956.9% | ||
| Q3 24 | -87.9% | — | ||
| Q2 24 | -179.8% | -164.0% | ||
| Q1 24 | — | -472.0% | ||
| Q4 23 | -56.9% | -30.0% | ||
| Q3 23 | -50.4% | — |
| Q2 25 | — | $-0.95 | ||
| Q1 25 | — | $-0.82 | ||
| Q4 24 | $-0.17 | $-0.89 | ||
| Q3 24 | $-0.18 | — | ||
| Q2 24 | $-0.21 | $-0.58 | ||
| Q1 24 | — | $-0.69 | ||
| Q4 23 | $-0.19 | $-0.25 | ||
| Q3 23 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $621.1K | $335.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.1M | $971.5M |
| Total Assets | $37.4M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $335.8M | ||
| Q1 25 | — | $90.0M | ||
| Q4 24 | $621.1K | $120.3M | ||
| Q3 24 | $116.9K | — | ||
| Q2 24 | $528.3K | $67.6M | ||
| Q1 24 | — | $93.5M | ||
| Q4 23 | $4.0M | $110.0M | ||
| Q3 23 | $2.0M | — |
| Q2 25 | — | $971.5M | ||
| Q1 25 | — | $786.2M | ||
| Q4 24 | $2.1M | $835.6M | ||
| Q3 24 | $4.2M | — | ||
| Q2 24 | $8.6M | $684.9M | ||
| Q1 24 | — | $711.2M | ||
| Q4 23 | $18.1M | $395.0M | ||
| Q3 23 | $22.3M | — |
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $918.3M | ||
| Q4 24 | $37.4M | $978.0M | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $43.5M | $826.0M | ||
| Q1 24 | — | $868.3M | ||
| Q4 23 | $50.2M | $575.8M | ||
| Q3 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-59.9M |
| Free Cash FlowOCF − Capex | — | $-60.6M |
| FCF MarginFCF / Revenue | — | -527.9% |
| Capex IntensityCapex / Revenue | — | 6.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-250.5M |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-59.9M | ||
| Q1 25 | — | $-79.2M | ||
| Q4 24 | $-1.1M | $-61.8M | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-3.2M | $-42.9M | ||
| Q1 24 | — | $-39.6M | ||
| Q4 23 | $1.4M | $8.0M | ||
| Q3 23 | $-5.4M | — |
| Q2 25 | — | $-60.6M | ||
| Q1 25 | — | $-79.6M | ||
| Q4 24 | — | $-62.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-47.6M | ||
| Q1 24 | — | $-47.0M | ||
| Q4 23 | — | $-3.6M | ||
| Q3 23 | — | — |
| Q2 25 | — | -527.9% | ||
| Q1 25 | — | -360.3% | ||
| Q4 24 | — | -848.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -185.7% | ||
| Q1 24 | — | -456.8% | ||
| Q4 23 | — | -7.5% | ||
| Q3 23 | — | — |
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 18.3% | ||
| Q1 24 | — | 72.0% | ||
| Q4 23 | — | 24.3% | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
